New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 11, 2012
19:03 EDTSCRApexigen announces initiation of clinical trials by its partner, Simcere Pharma
Apexigen, an emerging biopharmaceutical company dedicated to the discovery and development of best-in-class therapeutic monoclonal antibodies, announced that its partner, Simcere Pharmaceutical Group of Nanjing, received approval from the State Food and Drug Administration of China to begin first-in-man trials with APX003, which is also known as BD0801, for the treatment of cancer. With this approval, APX003/BD0801 becomes the first humanized monoclonal antibody derived from Apexigen's proprietary antibody technology platform to enter human trials.
News For SCR From The Last 14 Days
Check below for free stories on SCR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SCR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use